Housecall Pro Integrates with AI Mode in Google Search to Turn Home Service Searches into Booked Jobs 
Pitches and Keynote Speakers Are Confirmed for Blue Magic Netherlands on November 17 
The 34th Hong Kong International Optical Fair opens today 
CMS (867.HK/8A8.SG): Ruxolitinib Phosphate Cream Approved in Singapore, Filling Gap in Vitiligo Treatment 
Payment Cards Group (A3A PayTech) Joins HKMA’s Agentic Finance Expert Group Expel and Armis Partner to Protect Connected Assets from Cyber Threats
Leading Provider of MDR Capabilities Teams Up with Asset Intelligence Platform to Provide Critical Coverage…
ADTRAN, Inc. to Meet with Investors at the Rosenblatt Securities The Age of AI Scaling Technology Summit on June 10, 2022
HUNTSVILLE, Ala.–(BUSINESS WIRE)–ADTRAN®, Inc., (NASDAQ: ADTN), a leading provider of next-generation networking solutions, announced today…
CORRECTING and REPLACING Core Scientific Announces May Updates
Operating over 170,000 owned and colocated ASICs servers in the Company’s data centers Produced over…
Windstream Wholesale offers coast-to-coast 400 Gigabit routes
LITTLE ROCK, Ark.–(BUSINESS WIRE)–Windstream Wholesale, a leading provider of advanced optical solutions, with its first…
Victory Park Capital Bolsters Legal Finance Team with Additions of Chad Clamage and Ahmed Eltamami
CHICAGO–(BUSINESS WIRE)–Victory Park Capital (“VPC”), a leading global alternative investment firm, today announced the additions…
Emera Technologies and NOVONIX Launch Made-In-Atlantic-Canada Microgrid Battery
HALIFAX, Nova Scotia & BRISBANE, Australia–(BUSINESS WIRE)–Today Emera Technologies Limited, a subsidiary of Emera Inc….
Augmentt and SeedPod Bring to Market Cyber Insurance Program for MSPs and their Customers
SeedPod Cyber Rewards channel partners using Augmentt Discover and Augmentt Secure to improve security posture…
Menarini Group and Radius Health, Inc. present a subgroup analysis from the elacestrant pivotal phase 3 EMERALD clinical trial at the 2022 American Society of Clinical Oncology (ASCO) Annual Meeting
Subgroup analysis of patients with no prior chemotherapy in EMERALD: A phase 3 trial evaluating…
UPDATE — Enzo Biochem to Report Third Quarter 2022 Financial Results and Business Update on Thursday, June 9th
Conference Call and Webcast Scheduled for June 10, 2022, 8:30 am ET NEW YORK, NY,…
Amarin Announces Comprehensive Cost Reduction Plan to Address Market Dynamics in U.S. Business
— Company Expects to Achieve Approximately $100 Million in Cost Savings Over the Next 12…
Treosulfan Pivotal Study Results Published
Study’s primary endpoint and key secondary endpoints were met Study found event-free survival and overall…
Aquestive Therapeutics, Inc. Announces $8.5 Million Registered Direct Offering
WARREN, N.J., June 06, 2022 (GLOBE NEWSWIRE) — Aquestive Therapeutics, Inc. (NASDAQ: AQST), a pharmaceutical…
Amarin Appoints Tom Reilly as New Chief Financial Officer
— Experienced Executive Brings More Than Twenty Years of Global Financial Leadership to Amarin —…
Xalud Therapeutics CEO to Participate in Two Gene Therapy Focused Panels at BIO International Convention 2022
NEW YORK, June 06, 2022 (GLOBE NEWSWIRE) — Xalud Therapeutics, a clinical-stage biotechnology company developing…
AltruBio to Present at the 2022 BIO International Convention
Judy Chou, Ph.D. President and CEO SAN FRANCISCO, June 06, 2022 (GLOBE NEWSWIRE) — AltruBio…
Jasper Therapeutics Announces Annual Virtual Stockholders Meeting to be Held on Thursday, June 23, 2022
REDWOOD CITY, Calif., June 06, 2022 (GLOBE NEWSWIRE) — Jasper Therapeutics, Inc. (Nasdaq: JSPR), a…
Madrigal Pharmaceuticals Supports International NASH Day on June 9
Company expands its partnerships with leading patient advocacy groups to improve NASH education and patient…
Novartis Tafinlar® (dabrafenib) + Mekinist® (trametinib) demonstrates unprecedented efficacy in pediatric patients with BRAF V600 low-grade gliomas in Phase II/III study
Treatment with targeted therapies Tafinlar + Mekinist resulted in 47% ORR versus chemotherapy (11%) and…
IO Biotech to Participate in the 2022 BIO International Convention
NEW YORK, June 06, 2022 (GLOBE NEWSWIRE) — IO Biotech (Nasdaq: IOBT), a clinical-stage biopharmaceutical…
Portage Biotech Summarizes Data Presented at ASCO 2022 Annual Meeting Including Updates from Ongoing PORT-2 Study
Preliminary data from the Phase 1/2 trial of PORT-2 demonstrates favorable safety and tolerability as…